White House to announce drug pricing deal with Regeneron, source says
WASHINGTON, April 23 (Reuters) – The White House will announce a drug pricing deal with Regeneron Pharmaceuticals on…
SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
Genetic testing company 23andMe to re-auction over 15 million customers’ DNA data with bid starting at $305mn — Details
Bankrupt genetic analysis company 23andMe said it will conduct a second auction for its DNA data cache, with…